Intra-Cellular Therapies Cash from Investing (TTM) Analysis

Intra-Cellular Therapies Inc (ITCI)

70.97 +2.17 (+3.15%) USD | NASDAQ | May 06, 16:00

70.97 0.00 (0.00%) After-Hours: 18:45

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	105.54M
September 30, 2023	108.38M
June 30, 2023	234.72M
March 31, 2023	177.20M
December 31, 2022	-128.37M
September 30, 2022	-127.13M
June 30, 2022	-169.52M
March 31, 2022	-157.96M
December 31, 2021	280.34M
September 30, 2021	52.50M
June 30, 2021	-154.49M
March 31, 2021	-211.04M
December 31, 2020	-480.30M
September 30, 2020	-266.22M
June 30, 2020	-82.77M
March 31, 2020	-20.29M
December 31, 2019	177.44M
September 30, 2019	153.85M
June 30, 2019	141.87M

Date	Value
March 31, 2019	116.11M
December 31, 2018	134.64M
September 30, 2018	-31.39M
June 30, 2018	-22.49M
March 31, 2018	-20.57M
December 31, 2017	-92.72M
September 30, 2017	60.84M
June 30, 2017	76.65M
March 31, 2017	73.82M
December 31, 2016	92.26M
September 30, 2016	-160.35M
June 30, 2016	-258.91M
March 31, 2016	-285.51M
December 31, 2015	-361.78M
September 30, 2015	-112.29M
June 30, 2015	-84.54M
March 31, 2015	-133.44M
December 31, 2014	-66.73M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-480.30M

Minimum

Dec 2020

280.34M

Maximum

Dec 2021

-19.28M

Average

-20.29M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks